Judge Enjoins FDA From Barring Truthful, Nonmisleading Off-Label Drug Promotion

Mealey's (August 19, 2015, 11:41 AM EDT) -- NEW YORK — A New York federal judge on Aug. 7 ruled that Amarin Pharma Inc. proposes to make “truthful and non-misleading” statements about its prescription fish oil drug and that...
To view the full article, register now.